'My motivation is helping IMI reach its big achievements'
Maria Beatriz Da Silva Lima, Chair of the Scientific Committee
The IMI Scientific Committee is an advisory group within IMI. It is currently composed of 10 members and 1 ad hoc member that have been appointed further to suggestions made by the States Representatives Group. The Scientific Committee members are top experts from a range of different fields and participate in their individual capacity. They are appointed for a term of two years, renewable once.
The role of the Scientific Committee
The Committee gives strategic science-based recommendations to IMI and advises on the continued relevance of the Strategic Research Agenda and the scientific priorities. It is also formally consulted on our topic texts – which are based on the scientific priorities – before our Calls for proposals are launched.
More specifically, the Scientific Committee provides advice on:
- scientific priorities to be included in the Strategic Research Agenda taking into account related activities in Horizon 2020;
- scientific priorities to be addressed in the IMI Annual Work Plans;
- scientific achievements described in the IMI Annual Activity Reports.
When requested by IMI, the members of the Scientific Committee are required to provide their consolidated advice in writing. Scientific Committee members also take part in IMI’s Strategic Governing Groups.
Chair and Vice-Chair
The current Chair is Maria Beatriz Da Silva Lima (Portugal) and the Vice-Chair is Isabelle Bekeredjian-Ding (Germany). The Chair and the Vice-Chair are elected for a period of two years. Their current mandate ends on 30 September 2018.
The Scientific Committee Chair attends meetings of the IMI Governing Board as an observer and takes part in the deliberations, but has no voting rights.
More information about the Scientific Committee is available in the Scientific Committee's Rules of Procedure.
The Scientific Committee meets at least twice per year, usually at the IMI Programme Office in Brussels.
Cooperation with the IMI States Representatives Group
The Scientific Committee collaborates with the IMI States Representatives Group. The two bodies meet once a year to exchange views and discuss common areas of interest, such as IMI’s scientific priorities, and ways to enhance involvement of SMEs and patients into IMI activities.
Maria Beatriz Da Silva Lima
Chair of the Scientific Committee
Corinne de Vries
ad hoc member
Head of Science and Innovation Support, Human Medicines Research & Development Support Division, European Medicines Agency, London, UK
Vice-Chair of the Scientific Committee
Head of Division Microbiology, Paul-Ehrlich-Institut, Langen, GERMANY
Head of the Institute of Pharmacy University of Innsbruck and CSO, ThioMatrix Forschungs & Beratungs GmbH, Innsbruck, AUSTRIA
Director, Spanish National Cancer Research Centre (CNIO) and head of Telomeres and Telomerase Group, Madrid, SPAIN
Professor of Translational Science, School of Medicine, University College Dublin (UCD) and Principal Investigator, UCD Conway Institute of Biomolecular and Biomedical Research, Dublin, IRELAND; Co-founder PROTAGEN AG, Dortmund, GERMANY
Head of the Department of Public Health, Luxembourg Institute of Health, LUXEMBOURG
Professor of Health Economics & Head of Institute, Department of Health Policy and Health Economics, Institute of Economics, Faculty of Social Sciences, Eötvös Loránd University, Budapest, HUNGARY
Research Professor at the Institute for Health and Welfare, University of Helsinki, FINLAND
Professor of molecular biology at the Institute of Technology, University of Tartu, ESTONIA
Head of the Experimental Neurology Laboratory, Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milano, ITALY